Nitroglycerin Tablet
Product Images NDC 51662-1445

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 51662-1445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rfid Label (51662 1445 1 Rfid)

Rfid Label (51662 1445 1 Rfid)
The image shows a white label with a Data Matrix barcode on the right and multiple coded numbers on the left, including GS1 Application Identifiers such as (01), (17), (21), and (10) followed by corresponding numeric and alphanumeric strings. Below the codes, text instructs to "SEE MANUFACTURE'S INSERT" and states the product is distributed by HF Acquisitions Co., LLC in Mukilteo, WA 98275. The label corresponds to Nitroglycerin, sublingual tablet, .4 mg strength, distributed by HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Principal Display (51662 1445 2 Nitroglycerin Sublingual Tablets Usp 0.4mgtablet 25tabs Pouch Label Image)

Principal Display (51662 1445 2 Nitroglycerin Sublingual Tablets  Usp 0.4mgtablet 25tabs Pouch Label Image)
Label for NITROGLYCERIN sublingual tablets USP, 0.4 mg strength, with a package size of 25 tablets. The label includes NDC code 51662-1445-2, lot number 789210, and expiration date 2030-09-19. It also contains pharmacist dispensing information, storage conditions, and distributor details for HF Acquisition Co LLC.*
FDA Label Image

Principal Display (51662 1445 3 Nitroglycerin Sublingual Tablets Usp 0.4mgtablet 25tabs (case Of 24) Case Label Image)

Principal Display (51662 1445 3 Nitroglycerin Sublingual Tablets  Usp 0.4mgtablet 25tabs (case Of 24) Case Label Image)
NITROGLYCERIN sublingual tablets label showing 0.4 mg strength, package count of 25 tablets (case of 24). The label includes NDC 51662-1445-3, lot number, and expiration date 2030-09-19. It is distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The label notes the requirement to dispense patient information and storage instructions at controlled room temperature.*
FDA Label Image

Bottle Label (Bottle Label)

Bottle Label (Bottle Label)
NITROGLYCERIN sublingual tablets, 0.4 mg per tablet, packaged by Glenmark and later labeled for HF Acquisition Co LLC, DBA HealthFirst. The label includes dosage information, storage instructions, and manufacturer details, with a note requesting pharmacists to dispense patient information separately. The package contains 25 tablets.*
FDA Label Image

Clinical (Clinical P)

Clinical (Clinical P)
Table displaying mean nitroglycerin pharmacokinetic values including Cmax, Tmax, AUC, and half-life for two dosage regimens of nitroglycerin sublingual tablets: 2 x 0.3 mg and 1 x 0.6 mg. Data include mean values with standard deviations.*
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
A data table listing nitroglycerin tablet imprints and their associated NDC codes and packaging types. Tablets of strengths 0.3 mg, 0.4 mg, and 0.6 mg are debossed with numeric codes '1', '2', and '3' respectively on one side and a 'C' on the other. Packaging options include bottles of 100 tablets and convenience packages for the 0.4 mg strength.*
FDA Label Image

Logo 2 (Logo 2)

FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of nitroglycerin, showing its molecular arrangement with nitrate groups attached to the glycerin backbone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.